-
Je něco špatně v tomto záznamu ?
Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1
D Cerny, NK Canova, J Martinek, A Horinek, E Kmonickova, Z Zidek, H Farghali
Jazyk angličtina Země Spojené státy americké
Grantová podpora
NR9379
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
- MeSH
- alanintransaminasa MeSH
- analýza rozptylu MeSH
- apoptóza účinky léků MeSH
- cytoprotekce MeSH
- financování organizované MeSH
- hemoxygenasa-1 metabolismus MeSH
- hepatocyty metabolismus účinky léků ultrastruktura MeSH
- imobilizované buňky MeSH
- krysa rodu rattus MeSH
- kultivované buňky MeSH
- nádorové biomarkery metabolismus MeSH
- oxid dusnatý metabolismus MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- potkani Wistar MeSH
- silymarin farmakologie MeSH
- stilbeny farmakologie MeSH
- synthasa oxidu dusnatého, typ II metabolismus MeSH
- terc-butylhydroperoxid toxicita MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
The aim of this work was to study the effects of resveratrol (RES) as compared to silymarin (SM) pretreatments on tert-butylhydroperoxide (tBH) induced apoptotic/necrotic markers in hepatocytes. Hepatocyte in cultures (48 h) and in perifused immobilized agarose threads (5h) were used as cellular systems. Hepatocyte apoptosis was estimated morphologically using Annexin-V combined with propidium iodide, or toluidine blue staining. Hepatocyte viability and functionality were evaluated by ALT and urea synthesis. Nitric oxide (NO) and carbon monoxide involvements were also examined. Resveratrol and silymarin reduced tBH-induced hepatocyte toxic effects in short term experiments (5h) as measured by a significant reduction in ALT and NO increase produced by tBH. Both inducible nitric oxide synthase (NOS-2) and hemoxygenase-1 (HO-1) gene expression were increased by tBH and reduced by both RES and SM pretreatments. Morphologically, there were ameliorations in both apoptotic and necrotic markers under RES treatment and were similar to biochemical findings. In addition, RES improved hepatocyte stability in both cellular systems. It may be concluded that resveratrol and sylimarin ameliorative effects on tBH hepatocyte toxicity are comparable; involve NOS-2 and HO-1 expression and should be re-evaluated in various in vitro and in vivo experimental conditions.
- 000
- 03416naa 2200529 a 4500
- 001
- bmc11006734
- 003
- CZ-PrNML
- 005
- 20140327105516.0
- 008
- 110405s2009 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Černý, Dalibor $7 jx20101201018
- 245 10
- $a Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1 / $c D Cerny, NK Canova, J Martinek, A Horinek, E Kmonickova, Z Zidek, H Farghali
- 314 __
- $a Institute of Pharmacology, 1st Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague 2, Czech Republic.
- 520 9_
- $a The aim of this work was to study the effects of resveratrol (RES) as compared to silymarin (SM) pretreatments on tert-butylhydroperoxide (tBH) induced apoptotic/necrotic markers in hepatocytes. Hepatocyte in cultures (48 h) and in perifused immobilized agarose threads (5h) were used as cellular systems. Hepatocyte apoptosis was estimated morphologically using Annexin-V combined with propidium iodide, or toluidine blue staining. Hepatocyte viability and functionality were evaluated by ALT and urea synthesis. Nitric oxide (NO) and carbon monoxide involvements were also examined. Resveratrol and silymarin reduced tBH-induced hepatocyte toxic effects in short term experiments (5h) as measured by a significant reduction in ALT and NO increase produced by tBH. Both inducible nitric oxide synthase (NOS-2) and hemoxygenase-1 (HO-1) gene expression were increased by tBH and reduced by both RES and SM pretreatments. Morphologically, there were ameliorations in both apoptotic and necrotic markers under RES treatment and were similar to biochemical findings. In addition, RES improved hepatocyte stability in both cellular systems. It may be concluded that resveratrol and sylimarin ameliorative effects on tBH hepatocyte toxicity are comparable; involve NOS-2 and HO-1 expression and should be re-evaluated in various in vitro and in vivo experimental conditions.
- 650 _2
- $a alanintransaminasa $7 D000410
- 650 _2
- $a analýza rozptylu $7 D000704
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a imobilizované buňky $7 D018914
- 650 _2
- $a cytoprotekce $7 D019610
- 650 _2
- $a hemoxygenasa-1 $x metabolismus $7 D051547
- 650 _2
- $a hepatocyty $x metabolismus $x účinky léků $x ultrastruktura $7 D022781
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a synthasa oxidu dusnatého, typ II $x metabolismus $7 D052247
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a silymarin $x farmakologie $7 D012838
- 650 _2
- $a stilbeny $x farmakologie $7 D013267
- 650 _2
- $a nádorové biomarkery $x metabolismus $7 D014408
- 650 _2
- $a terc-butylhydroperoxid $x toxicita $7 D020122
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Kutinová-Canová, Nikolína $7 xx0103768
- 700 1_
- $a Martínek, Jindřich, $d 1938-2018 $7 jn20000710438
- 700 1_
- $a Hořínek, Aleš, $d 1961- $7 xx0061416
- 700 1_
- $a Kmoníčková, Eva, $d 1962- $7 jo2002105217
- 700 1_
- $a Zídek, Zdeněk $7 jk01152582
- 700 1_
- $a Farghali, Hassan
- 773 0_
- $t Nitric Oxide $w MED00004882 $g Roč. 20, č. 1 (2009), s. 1-8
- 910 __
- $a ABA008 $b x $y 7 $z 0
- 990 __
- $a 20110412125811 $b ABA008
- 991 __
- $a 20140327105551 $b ABA008
- 999 __
- $a ok $b bmc $g 834358 $s 698850
- BAS __
- $a 3
- BMC __
- $a 2009 $b 20 $c 1 $d 1-8 $m Nitric oxide $n Nitric oxide $x MED00004882
- GRA __
- $a NR9379 $p MZ0
- LZP __
- $a 2011-4B/ewme